CELEBRATION, Fla., Nov. 20, 2025 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today provided a business update and reported financial results for the third quarter ended September 30, 2025. Q3 2025 Financial HighlightsTotal revenue increased 3.2% year-over-year to $20.2 million for the third quarter ended September 30, 2025 from $19.6 million for the third quarter ended September 30, 2024. Residential real estate services revenue increased by approximately $286 thousand to $16.8 million, or 1.7% for the third quarter ended September 30, 2025 from $16.5 million for the third quarter ended September 30, 2024 Property management revenue increased by approximately $255 thousand to approximately $3.1 million, or 8.9%, for the third quarter ended September...

Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug’s commercial potential In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY Sol-Gel signed an additional agreement with Viatris covering Australia and New Zealand for both EPSOLAY and TWYNEONESS ZIONA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the third quarter ending September 30, 2025, and provided a corporate update. Q3 2025 and Recent Corporate DevelopmentsSol-Gel’s ongoing Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, for which top-line results...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; Full Operational Capacity Expected by Year-End 2025 Balance Sheet Strengthened with $30 Million Equity Financing Third Quarter 2025 Revenue of $5.4 Million, Up 23% Year-over-Year Conference Call Today, November 20, 2025, at 8:30 a.m. Eastern Time YAVNE, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the third quarter ended September 30, 2025, and provided a corporate update. “We continued to execute our growth strategy this quarter, advancing both our operational capabilities and our late-stage clinical programs,” said Ofer Gonen, Chief Executive...

Launches the Consumer First Formula with four strategic priorities to drive sustainable long-term growth Third-quarter net sales of $1.6 billion, down 1%. Earnings per diluted share of $0.37; Adjusted earnings per diluted share of $0.35 Q4 and full-year 2025 guidance lowered reflecting current business trends and continuation of recent macro consumer pressuresCOLUMBUS, Ohio, Nov. 20, 2025 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) today reported third quarter 2025 results. Daniel Heaf, chief executive officer of Bath & Body Works, commented, “Today, we are excited to announce a comprehensive transformation plan to revitalize Bath & Body Works across brand, product, and marketplace. This plan, the Consumer First Formula, focuses our investments in our four largest revenue driving opportunities –...

(all amounts are expressed in millions of U.S. dollars, excluding per share amounts and unless otherwise stated) TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) —  Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the fourth quarter and fiscal year ended September 30, 2025. “Our business demonstrated resilience and competitive strength throughout 2025 as we consistently launched new clients, expanded market share, and maintained strong financial discipline. We launched 10 new clients and one new channel in U.S. Appraisal and Canada, and both these segments continued to generate solid positive Adjusted EBITDA(A). We expanded our U.S. Title business by adding seven new clients, including a second...

Strong Fourth Quarter Fueled by Market Share Expansion and Operating Leverage Annual GMV Surpasses $1.5 Billion Milestone with Record Number of Auction Participants BETHESDA, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), the leading global provider of e-commerce marketplaces and software solutions powering the circular economy, today announced its financial results for its fiscal quarter and year ended September 30, 2025: Fourth Quarter Results:Gross Merchandise Volume (GMV) of $404.5 million, up 12%, and Revenue of $118.1 million, up 10% GAAP Net Income of $7.8 million, up 23%, and GAAP Diluted Earnings Per Share (EPS) of $0.24, up 20% Non-GAAP Adjusted EBITDA of $18.5 million, up 28%, and Non-GAAP Adjusted EPS of $0.37, up 16% Cash balances of $185.8 million1 with zero financial...

BEIJING, Nov. 20, 2025 (GLOBE NEWSWIRE) — Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial and Operational SnapshotsNet revenues were RMB523.0 million (US$73.5 million), compared to RMB491.3 million in the third quarter of 2024. Gross billings (non-GAAP) were RMB349.2 million (US$49.0 million), compared to RMB360.3 million in the third quarter of 2024. Gross profit was RMB462.7 million (US$65.0 million), compared to RMB409.2 million in the third quarter of 2024. Net income was RMB125.4 million (US$17.6 million), compared to RMB89.3 million in the third quarter of 2024. Net income margin1...

Luxembourg – 20 November 2025 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, ISIN: LU0075646355, the Company) announced today results of Subsea7 Group (the Group, Subsea7) for the third quarter which ended 30 September 2025. Highlights Third quarter Adjusted EBITDA of $407 million, up 27% on the prior year period, equating to a margin of 22% Solid operational and financial performance from both Subsea and Conventional and Renewables, with Adjusted EBITDA margins of 24% and 17%, respectively Full year 2025 revenue is expected to be in a range between $6.9 and 7.1 billion while margins are expected to be between 20 and 21% Record high, quality backlog of $13.9 billion including $6.0 billion for execution in 2026 and $3.8 billion in 2027 Based on our firm backlog of contracts for execution in 2026, we expect revenue within a range of $7.0...

GUANGZHOU, China, Nov. 20, 2025 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2025. Recent Business UpdatesTherapy SelectionPresented study results at the Cell Reports Medicine on esophageal squamous cell carcinoma in September 2025. “Integrating ctDNA with clinical response evaluation improves residual disease detection post-neoadjuvant chemoradiotherapy to support organsparing strategies and that postoperative ctDNA stratifies recurrence risk beyond pathological response to inform adjuvant immunotherapy decisions”.Early DetectionPROMISE study test results presented at The Innovation...

Nilfisk CEO, Jon Sintorn, comments on Q3 2025 results: “In the third quarter of 2025, we continued to improve our cost structure and competitiveness to build resilience despite ongoing macroeconomic uncertainty. I was pleased to see growth in our Professional Business across all regions. Positively, EMEA delivered organic growth for the seventh consecutive quarter, and APAC achieved organic growth for the third consecutive quarter. Americas also grew in the quarter over a weak quarter same period last year. External headwinds, including tariffs and softer end-user demand, affected our margin. However, we maintained steady operational performance, reduced our cost, and improved free cash flow. A number of structural changes and decisions were executed in the quarter to improve our profitability and competitiveness. These changes and decisions...